205 related articles for article (PubMed ID: 23086971)
21. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Ward NC; Wu JH; Clarke MW; Puddey IB; Burke V; Croft KD; Hodgson JM
J Hypertens; 2007 Jan; 25(1):227-34. PubMed ID: 17143195
[TBL] [Abstract][Full Text] [Related]
22. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.
Meyer MF; Lieps D; Schatz H; Pfohl M
Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of ivabradine and atenolol on heart rate and echocardiographic variables of left heart function in healthy cats.
Riesen SC; Schober KE; Cervenec RM; Bonagura JD
J Vet Intern Med; 2011; 25(3):469-76. PubMed ID: 21418320
[TBL] [Abstract][Full Text] [Related]
24. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.
Rudofsky G; Reismann P; Grafe IA; Konrade I; Djuric Z; Tafel J; Buchbinder S; Zorn M; Humpert PM; Hamann A; Morcos M; Nawroth PP; Bierhaus A
Horm Metab Res; 2007 Sep; 39(9):665-71. PubMed ID: 17846974
[TBL] [Abstract][Full Text] [Related]
25. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
[TBL] [Abstract][Full Text] [Related]
26. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk.
Rosano GM; Aversa A; Vitale C; Fabbri A; Fini M; Spera G
Eur Urol; 2005 Feb; 47(2):214-20; discussion 220-2. PubMed ID: 15661417
[TBL] [Abstract][Full Text] [Related]
27. Heart rate reduction by inhibition of If or by beta-blockade has different effects on postsystolic wall thickening.
Lucats L; Ghaleh B; Colin P; Monnet X; Bizé A; Berdeaux A
Br J Pharmacol; 2007 Feb; 150(3):335-41. PubMed ID: 17179940
[TBL] [Abstract][Full Text] [Related]
28. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
Taneva E; Borucki K; Wiens L; Makarova R; Schmidt-Lucke C; Luley C; Westphal S
Am J Cardiol; 2006 Apr; 97(7):1002-6. PubMed ID: 16563905
[TBL] [Abstract][Full Text] [Related]
29. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
[TBL] [Abstract][Full Text] [Related]
30. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease.
Lekakis JP; Protogerou A; Papamichael C; Vamvakou G; Ikonomidis I; Fici F; Mavrikakis M
Cardiovasc Drugs Ther; 2005 Aug; 19(4):277-81. PubMed ID: 16187009
[TBL] [Abstract][Full Text] [Related]
31. Acute hyperhomocysteinemia impairs endothelium function in subjects with type 2 diabetes mellitus.
Doupis J; Eleftheriadou I; Kokkinos A; Perrea D; Pavlatos S; Gonis A; Katsilambros N; Tentolouris N
Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):453-8. PubMed ID: 20200816
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.
Settergren M; Böhm F; Rydén L; Pernow J
Eur Heart J; 2008 Jul; 29(14):1753-60. PubMed ID: 18441323
[TBL] [Abstract][Full Text] [Related]
33. Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy.
Harmer JA; Keech AC; Veillard AS; Skilton MR; Marwick TH; Watts GF; Meredith IT; Celermajer DS;
Atherosclerosis; 2015 Sep; 242(1):295-302. PubMed ID: 26233916
[TBL] [Abstract][Full Text] [Related]
34. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
Doesch AO; Celik S; Ehlermann P; Frankenstein L; Zehelein J; Koch A; Katus HA; Dengler TJ
Transplantation; 2007 Oct; 84(8):988-96. PubMed ID: 17989604
[TBL] [Abstract][Full Text] [Related]
35. Mechanical vs intrinsic components in the improvement of brachial arterial compliance. Comparison of the effects of atenolol versus ramipril in hypertensive patients.
Armentano RL; Graf S; Ramírez AJ; Espinosa JD; Brandani L; Baglivo H; Sánchez R
Medicina (B Aires); 2001; 61(5 Pt 1):535-40. PubMed ID: 11721319
[TBL] [Abstract][Full Text] [Related]
36. Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD).
Siniarski A; Haberka M; Mostowik M; Gołębiowska-Wiatrak R; Poręba M; Malinowski KP; Gąsior Z; Konduracka E; Nessler J; Gajos G
Atherosclerosis; 2018 Apr; 271():148-155. PubMed ID: 29518747
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of ivabradine and atenolol in patients with moderate mitral stenosis in sinus rhythm.
Rajesh GN; Sajeer K; Sajeev CG; Bastian C; Vinayakumar D; Muneer K; Haridasan V; Mathew D; George B; Krishnan MN
Indian Heart J; 2016; 68(3):311-5. PubMed ID: 27316483
[TBL] [Abstract][Full Text] [Related]
38. Effect of folic acid on endothelial function following acute myocardial infarction.
Moens AL; Claeys MJ; Wuyts FL; Goovaerts I; Van Hertbruggen E; Wendelen LC; Van Hoof VO; Vrints CJ
Am J Cardiol; 2007 Feb; 99(4):476-81. PubMed ID: 17293188
[TBL] [Abstract][Full Text] [Related]
39. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart.
Ceconi C; Cargnoni A; Francolini G; Parinello G; Ferrari R
Cardiovasc Res; 2009 Oct; 84(1):72-82. PubMed ID: 19477966
[TBL] [Abstract][Full Text] [Related]
40. Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease.
Jambrik Z; Venneri L; Varga A; Rigo F; Borges A; Picano E
Am Heart J; 2004 Oct; 148(4):684-9. PubMed ID: 15459601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
